Masterclass Certificate in Lung Cancer: Molecular Diagnostics
-- ViewingNowThe Masterclass Certificate in Lung Cancer: Molecular Diagnostics is a comprehensive course that provides learners with essential skills in the rapidly evolving field of lung cancer diagnostics. This course emphasizes the importance of understanding molecular biology, genetics, and cutting-edge diagnostic techniques, which are crucial for identifying lung cancer at its earliest stages and improving patient outcomes.
6,719+
Students enrolled
GBP £ 140
GBP £ 202
Save 44% with our special offer
ě´ ęłźě ě ëí´
100% ě¨ëźě¸
ě´ëěë íěľ
ęłľě ę°ëĽí ě¸ěŚě
LinkedIn íëĄíě ěśę°
ěëŁęšě§ 2ę°ě
죟 2-3ěę°
ě¸ě ë ěě
ë기 ę¸°ę° ěě
ęłźě ě¸ëśěŹí
⢠Molecular Biology of Lung Cancer: Understanding the fundamental molecular mechanisms underlying lung cancer development and progression. This unit will cover key concepts such as oncogenes, tumor suppressor genes, and genomic instability. ⢠Molecular Techniques in Lung Cancer Diagnosis: An in-depth exploration of the various molecular techniques employed in the diagnosis of lung cancer, including PCR, FISH, and next-generation sequencing. ⢠Molecular Markers in Lung Cancer: A survey of the most important molecular markers used in lung cancer diagnosis and prognosis, such as EGFR, ALK, ROS1, and BRAF mutations. ⢠Liquid Biopsy and Circulating Tumor Cells: An examination of the emerging techniques for detecting circulating tumor cells and analyzing circulating tumor DNA in the blood of lung cancer patients. ⢠Molecular Genetic Testing in Lung Cancer: This unit will cover the latest advances in genetic testing for lung cancer, including the use of genomic arrays and panel testing. ⢠Molecular Targeted Therapy in Lung Cancer: An exploration of the molecular mechanisms underlying targeted therapies for lung cancer, including tyrosine kinase inhibitors, monoclonal antibodies, and immune checkpoint inhibitors. ⢠Molecular Diagnostics in Lung Cancer Screening: A discussion of the role of molecular diagnostics in lung cancer screening, including the use of biomarkers for risk stratification and early detection. ⢠Ethical and Legal Considerations in Molecular Diagnostics: An examination of the ethical and legal issues surrounding the use of molecular diagnostics in lung cancer, including genetic privacy, informed consent, and reimbursement. ⢠Advances in Molecular Diagnostics for Lung Cancer: A look at the latest developments and future directions in molecular diagnostics for lung cancer, including the use of artificial intelligence, machine learning, and big data.
ę˛˝ë Ľ 경ëĄ
ě í ěęą´
- 죟ě ě ëí 기본 ě´í´
- ěě´ ě¸ě´ ëĽěë
- ěť´í¨í° ë° ě¸í°ëˇ ě ꡟ
- 기본 ěť´í¨í° 기ě
- ęłźě ěëŁě ëí íě
ěŹě ęłľě ěę˛Šě´ íěíě§ ěěľëë¤. ě ꡟěąě ěí´ ě¤ęłë ęłźě .
ęłźě ěí
ě´ ęłźě ě ę˛˝ë Ľ ę°ë°ě ěí ě¤ěŠě ě¸ ě§ěęłź 기ě ě ě ęłľíŠëë¤. ꡸ę˛ě:
- ě¸ě ë°ě 기ę´ě ěí´ ě¸ěŚëě§ ěě
- ęśíě´ ěë 기ę´ě ěí´ ęˇě ëě§ ěě
- ęłľě ě겊ě ëł´ěě
ęłźě ě ěąęłľě ěźëĄ ěëŁí늴 ěëŁ ě¸ěŚě뼟 ë°ę˛ ëŠëë¤.
ě ěŹëë¤ě´ ę˛˝ë Ľě ěí´ ě°ëŚŹëĽź ě ííëę°
댏롰 ëĄëŠ ě¤...
ě죟 돝ë ě§ëʏ
ě˝ě¤ ěę°ëŁ
- 죟 3-4ěę°
- 쥰기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- 죟 2-3ěę°
- ě 기 ě¸ěŚě ë°°ěĄ
- ę°ë°Ší ëąëĄ - ě¸ě ë ě§ ěě
- ě 체 ě˝ě¤ ě ꡟ
- ëě§í¸ ě¸ěŚě
- ě˝ě¤ ěëŁ
ęłźě ě ëł´ ë°ę¸°
íěŹëĄ ě§ëś
ě´ ęłźě ě ëšěŠě ě§ëśí기 ěí´ íěŹëĽź ěí ě˛ęľŹě뼟 ěě˛íě¸ě.
ě˛ęľŹěëĄ ę˛°ě ę˛˝ë Ľ ě¸ěŚě íë